Diagnostic tests for Alzheimer's disease: rationale, methodology, and challenges.
There has been a large increase in the amount of research seeking to define or diagnose Alzheimer's disease before patients develop dementia. If successful, this would principally have clinical benefits both in terms of treatment as well as risk modification. Moreover, a better method for diagnosing predementia disease would assist research which seeks to develop such treatments and risk modification strategies. The evidence-based definition of a diagnostic test's accuracy is fundamental to achieve the above goals and to address this, the Cochrane Collaboration has established a Diagnostic Test Accuracy group dedicated to examining the utility and accuracy of proposed tests in dementia and cognitive impairment. We present here the assumptions and observations underpinning the chosen methodology as well as the initial methodological approach decided upon.
Mason
S E
SE
Centre of Mental Health, Imperial College London, London W6 8LN, UK.
McShane
R
R
Ritchie
C W
CW
Biol Psychiatry. 2008 Nov 15;64(10):871-9
18723162
Neurology. 1991 Apr;41(4):479-86
2011243
Lancet Neurol. 2008 Sep;7(9):779-86
18672400
JAMA. 2003 May 28;289(20):2651-62
12771112
Lancet Neurol. 2009 Sep;8(9):791-801
19646924
Neurology. 1984 Jul;34(7):939-44
6610841
JAMA. 1998 Mar 4;279(9):688-95
9496988
Arch Neurol. 2009 Oct;66(10):1210-5
19822776
Arch Neurol. 1985 Nov;42(11):1097-105
2864910
JAMA. 2002 Aug 21;288(7):872-81
12186605
J Am Geriatr Soc. 2008 Aug;56(8):1424-33
18662209
Dement Geriatr Cogn Disord. 1998 Jul-Aug;9(4):219-26
9681644
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2
9330978
Lancet Neurol. 2007 Aug;6(8):734-46
17616482
Arch Gen Psychiatry. 2006 Aug;63(8):916-24
16894068
Mult Scler. 2009 Dec;15(12):1528-31
19995848